PLSE compared with EROC: revenue, margins and what each company keeps, and the suppliers and customers both name

PLSEPulse Biosciences, Inc.

Mkt capRevenueRevenue

EROCERock, Inc.

Mkt capRevenueRevenue

Compare

PLSEPulse Biosciences, Inc.

EROCERock, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PLSEPulse Biosciences, Inc.

52.94· pre 53.75· delayed

Mkt cap$4.1BRevenue$395,000Q3 FY26

EROCERock, Inc.

6.65· pre 6.86· delayed

Pre-marketNov 6 '26delayed

Mkt cap$319.9MRevenue$40MQ2 FY26

Compare

Pre-marketNov 6 '26delayed

PLSEPulse Biosciences, Inc.

EROCERock, Inc.

52.94pre 53.75delayed

Price

6.65pre 6.86delayed

$4.1B

Mkt cap

$319.9M

Q3 FY26$395,000

Revenue

$40MQ2 FY26

PLSE52.94vsEROC6.65Pre-marketNov 6 '26delayed

Earnings history

last 4 reports each · paired by recencyMethod ›

PLSE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.7%▲+10.90%×0.93

Q1 FY26±21.7%▼−3.84%×0.18

Feb 20 '26±19.0%▼−14.59%×0.77

Q3 FY25±28.5%▼−3.32%×0.12

EROC

No earnings history for EROC.

= impliedPLSE realized, solidEROC realized, hatchedOne scale, both sides: full bar = 29%× = |realized| ÷ impliedSource: market data